Explore more publications!
MarCom Europe
Submit Press Release

Press Releases

Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®
November 25, 2025

Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®

Indeterminate GlobeNewswire, Inc.
Mobilicom Expands Presence in European Union with New Customer Design Win for Systems to be Deployed for Protection and Security
November 25, 2025

Mobilicom Expands Presence in European Union with New Customer Design Win for Systems to be Deployed for Protection and Security

Indeterminate GlobeNewswire, Inc.
Demand for In-Game Advertising Market is forecasted to reach a value of US $18.23 billion by 2029
November 25, 2025

Demand for In-Game Advertising Market is forecasted to reach a value of US $18.23 billion by 2029

Neutral EIN Presswire
WuXi AppTec: Empowering European Biotech Growth Through Collaborative Ecosystem Building
November 25, 2025

WuXi AppTec: Empowering European Biotech Growth Through Collaborative Ecosystem Building

Neutral EIN Presswire
WuXi AppTec Strengthens Europe’s Biotech Ecosystem Through Partnerships and Innovation Networks
November 25, 2025

WuXi AppTec Strengthens Europe’s Biotech Ecosystem Through Partnerships and Innovation Networks

Neutral EIN Presswire
Dupixent® (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU)
November 25, 2025

Dupixent® (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU)

Indeterminate GlobeNewswire, Inc.
Press Release: Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria
November 25, 2025

Press Release: Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria

Indeterminate GlobeNewswire, Inc.
Insurance Chatbot Market : Opportunity Analysis and Industry Forecast, 2022 - 2032
November 27, 2025

Insurance Chatbot Market : Opportunity Analysis and Industry Forecast, 2022 - 2032

Neutral EIN Presswire
GENFIT Announces Appointment of new Chief Medical Officer
November 27, 2025

GENFIT Announces Appointment of new Chief Medical Officer

Indeterminate GlobeNewswire, Inc.
VALLOUREC RECEIVES INVESTMENT GRADE RATING FROM MOODY'S AND S&P
November 27, 2025

VALLOUREC RECEIVES INVESTMENT GRADE RATING FROM MOODY'S AND S&P

Indeterminate GlobeNewswire, Inc.
Billboard And Outdoor Advertising Market Trends and Analysis by Application, Vertical, Region, and Segment Forecast 2029
November 25, 2025

Billboard And Outdoor Advertising Market Trends and Analysis by Application, Vertical, Region, and Segment Forecast 2029

Neutral EIN Presswire
Members adopt panel report in frozen fries case, EU appeals ruling in steel duties dispute
November 24, 2025

Members adopt panel report in frozen fries case, EU appeals ruling in steel duties dispute

Indeterminate World Trade Organization
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 27, 2025

Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference

Indeterminate GlobeNewswire, Inc.
Spain Fines Meta Platforms for Unlawful Data Advantage
November 23, 2025

Spain Fines Meta Platforms for Unlawful Data Advantage

Indeterminate MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber

MENAFN

Indeterminate
Owned By Sawsan Dababneh & Ramzi AbdelJaber through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Amman, New York, Dubai

We welcome your feedback!
If you have comments or corrections, let us know.

DeanHouston Partners with Verified Market Research for Europe Car Washing System Market Study
November 24, 2025

DeanHouston Partners with Verified Market Research for Europe Car Washing System Market Study

Indeterminate GlobeNewswire, Inc.
Sword Health and Greek Government Join Forces to Deliver One of Europe’s First National Healthcare Transformation Initiatives Involving AI
November 24, 2025

Sword Health and Greek Government Join Forces to Deliver One of Europe’s First National Healthcare Transformation Initiatives Involving AI

Indeterminate GlobeNewswire, Inc.
GXO Announces Completion of Inaugural European Bond Offering
November 24, 2025

GXO Announces Completion of Inaugural European Bond Offering

Indeterminate GlobeNewswire, Inc.
Kickscale Delivers European Alternative to U.S. Revenue Intelligence with ISO 27001 Certification
November 24, 2025

Kickscale Delivers European Alternative to U.S. Revenue Intelligence with ISO 27001 Certification

Neutral EIN Presswire
Attention Long-Term Shareholders of Fortrea Holdings, Inc. (NASDAQ: FTRE); enCore Energy Corp. (NASDAQ: EU); Humana Inc. (NYSE: HUM); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
November 24, 2025

Attention Long-Term Shareholders of Fortrea Holdings, Inc. (NASDAQ: FTRE); enCore Energy Corp. (NASDAQ: EU); Humana Inc. (NYSE: HUM); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf

Indeterminate GlobeNewswire, Inc.
Enlivex Announces $212,000,000 Private Placement to Initiate World’s First Prediction Markets Digital Asset Treasury Strategy, via RAIN token Accumulation, and the Appointment of Matteo Renzi, Former Prime Minister of Italy, to its Board
November 24, 2025

Enlivex Announces $212,000,000 Private Placement to Initiate World’s First Prediction Markets Digital Asset Treasury Strategy, via RAIN token Accumulation, and the Appointment of Matteo Renzi, Former Prime Minister of Italy, to its Board

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions